Valuation : Mega Lifesciences

Market Cap 31.17B 943M 811M 765M 697M 1.3B 90.18B 1.32B 9.12B 3.51B 45.74B 3.54B 3.46B 145B P/E 2026 *
13.2x
P/E 2027 * 12.5x
Enterprise Value 26.55B 804M 691M 652M 594M 1.11B 76.82B 1.12B 7.76B 2.99B 38.96B 3.02B 2.95B 124B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.69x
Free-Float
38.66%
Yield 2026 *
4.92%
Yield 2027 * 5.31%
1 day+1.42%
1 week+2.14%
Current month-0.69%
1 month-7.74%
3 months+3.62%
6 months+5.15%
Current year+6.72%
1 week 35
Extreme 35
36.25
1 month 34.75
Extreme 34.75
39
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.6
Extreme 17.6
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 62 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/04/25 Buy

Chief Executive Officer

100,000 0.0115%
28/04/25 Buy

Chief Executive Officer

50,000 0.0057%
28/04/25 Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%+2.14%+11.72%-13.86% 943M
-0.11%-3.16%+48.82%+91.49% 1,001B
-0.27%-4.34%+51.52%+65.89% 642B
+1.63%-2.00%+20.49%+71.12% 451B
+0.43%-2.83%+29.25%+36.63% 340B
+0.90%-12.72%+11.12%+28.07% 263B
+1.17%-1.20%-0.79%+12.95% 247B
-2.25%-13.88%+37.33%+47.43% 207B
-2.03%-6.04%-18.81%-58.93% 197B
-0.58%-4.24%+25.65%+90.54% 180B
Average +0.51%-5.04%+21.63%+37.13% 352.73B
Weighted average by Cap. +0.50%-4.65%+31.89%+57.66%

Financials

2026 *2027 *
Net sales 14.35B 434M 373M 352M 321M 600M 41.51B 605M 4.2B 1.61B 21.05B 1.63B 1.59B 66.87B 15.66B 474M 408M 385M 350M 655M 45.32B 661M 4.58B 1.76B 22.99B 1.78B 1.74B 73.01B
Net income 2.23B 67.51M 58.05M 54.78M 49.9M 93.28M 6.45B 94.13M 652M 251M 3.27B 253M 248M 10.4B 2.49B 75.21M 64.68M 61.03M 55.59M 104M 7.19B 105M 727M 280M 3.65B 282M 276M 11.58B
Net Debt -4.62B -140M -120M -113M -103M -193M -13.36B -195M -1.35B -520M -6.77B -525M -513M -21.52B -4.72B -143M -123M -116M -106M -197M -13.66B -199M -1.38B -531M -6.93B -536M -525M -22B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
10/09/26 THB 35.75 +1.42% 744,041
09/09/26 THB 35.25 -1.40% 632,608
08/09/26 THB 35.75 0.00% 1,035,722
07/09/26 THB 35.75 -0.69% 734,348
04/09/26 THB 36.00 +2.86% 1,057,073
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
35.75THB
Average target price
42.71THB
Spread / Average Target
+19.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!